Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013;18(9):1060-1.
doi: 10.1634/theoncologist.2013-0121. Epub 2013 Aug 19.

Difference in therapeutic response between basal and nonbasal triple-negative breast cancers

François Bertucci  1 , Pascal Finetti, Patrice Viens, Daniel Birnbaum
Affiliations
Comment

Difference in therapeutic response between basal and nonbasal triple-negative breast cancers

François Bertucci et al. Oncologist. 2013.

Abstract

This study, which nicely complements a study recently published in The Oncologist, shows for the first time that triple-negative breast cancers are much more heterogeneous than basal breast cancers regarding the response to chemotherapy and the probability of response to molecularly targeted therapies.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Comment on

References

    1. Prat A, Adamo B, Cheang MC, et al. Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. The Oncologist. 2013;18:123–133. - PMC - PubMed
    1. Bertucci F, Finetti P, Cervera N, et al. How basal are triple-negative breast cancers? Int J Cancer. 2008;123:236–240. - PubMed
    1. Duffy MJ, McGowan PM, Crown J. Targeted therapy for triple-negative breast cancer: Where are we? Int J Cancer. 2012;131:2471–2477. - PubMed
    1. Bertucci F, Finetti P, Birnbaum D. Basal breast cancer: A complex and deadly molecular subtype. Curr Mol Med. 2012;12:96–110. - PMC - PubMed
    1. Parker JS, Mullins M, Cheang MC, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160–1167. - PMC - PubMed

Substances

LinkOut - more resources